{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraisinghealth.simplecast.com%2Fepisodes%2Fjournal-club-cart-QCjuSrAJ","width":444,"version":"1.0","type":"rich","title":"Journal Club: Engineering Logic into CAR T Therapies with Robbie Majzner","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/8bfdd457-9cd9-4577-bbed-a027587c6960/103ea12d-dd5b-4ef8-b398-ddf54dfbe24e/cover-art-3000x3000-no-grain-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/6b61f541-6b86-4a9f-a835-7b98273d586b\" height=\"200\" width=\"100%\" title=\"Journal Club: Engineering Logic into CAR T Therapies with Robbie Majzner\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, a16z Bio + Health investment partner Becky Pferdehirt chats with Robbie Majzner, an Assistant Professor of Pediatrics in the Division of Hematology and Oncology at Stanford, and co-founder of Link Cell Therapies."}